A previous study reported reduced glucagon suppression in individuals with CF and glucose intolerance during an oral glucose tolerance test (OGTT) (12), suggesting that functions of other islet cell types are also affected by the CFRD pathology. The gene discussed is GCG; the disease is cystic fibrosis-related diabetes.